So, the other night I posted about cash-only buprenorphine practices.
The next morning I find this in my mail.
Consulting services to help establish turn-key buprenorphine clinics with cash revenue models that use toxicology services to generate revenue and provide aggressive risk management. (It’s worth noting that I also get emails about treatment valuation conferences/services several times a week. That’s not a typo. Treatment valuation, not evaluation.)